Discovery of potent vascular endothelial growth factor receptor-2 inhibitors

Area of Science:

• Medicinal Chemistry
• Molecular Biology
• Computational Chemistry

Background:

• Uncontrolled angiogenesis is linked to pathological conditions like cancer.
• Vascular Endothelial Growth Factor (VEGF) is a key regulator of angiogenesis.
• VEGF receptor-2 (VEGFR-2) is a major mediator of VEGF effects and a critical anti-angiogenesis target.

Purpose of the Study:

• To design and synthesize novel VEGFR-2 inhibitors.
• To improve upon existing anthranilamide-based VEGFR-2 inhibitors.
• To identify compounds with enhanced potency and reduced cytotoxicity.

Main Methods:

• Computational analysis including docking and molecular dynamics simulations.
• Design and synthesis of new analogues based on computational findings.
• In vitro evaluation of synthesized compounds for VEGFR-2 inhibition and cytotoxicity.

Main Results:

• Identification of novel compounds targeting VEGFR-2.
• New analogues demonstrated increased potency compared to parent compounds.
• Synthesized inhibitors exhibited reduced cytotoxicity.

Conclusions:

• The study successfully designed and synthesized novel, potent, and less cytotoxic VEGFR-2 inhibitors.
• These findings offer a promising new avenue for anti-angiogenesis cancer therapies.
• Computational approaches combined with experimental validation are effective for drug discovery.